Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

Radiotherapy and Oncology

Volumn 92, Issue 1, 2009, Pages 4-14

  Pignon, Jean Pierre ^a   Maître, Aurélie le ^a   Maillard, Emilie ^a   Bourhis, Jean ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Chemotherapy; Head and neck cancer; Individual patient data; Meta analysis; Radiotherapy; Randomised clinical trials; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; HEAD AND NECK CARCINOMA; HUMAN; META ANALYSIS; MONOTHERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 66949128922     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.04.014     Document Type: Article

References (19)

1. Ferlay F, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press; 2004.
2. Pignon J.-P., Bourhis J., Domenge C., Désigné L., and On behalf of the MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 255 (2000) 949-955
3. Baujat B., Mahé C., Pignon J.-P., and Hill C. A graphical method for exploring heterogeneity in meta-analysis: application to a meta-analysis of 65 trials. Stat Med 21 (2002) 2641-2652
4. Pignon J.-P.., Le Maître A., Bourhis J., and On behalf of the MACH-NC Collaborative Group. Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69 (2007) S112-S114
5. Schemper M., and Smith T.L. A note on quantifying follow-up in studies of failure time. Control Clin Trials 17 (1996) 343-346
6. Yusuf S., Peto R., Lewis J., Collins R., and Sleight T. Beta blockade during and after myocardial infarction: an overview of randomised clinical trials. Prog Cardiovasc Dis 27 (1985) 335-371
7. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of randomized trials. N Engl J Med 333 (1995) 1444-1455
8. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med J 311 (1995) 899-909
9. Higgins J.P.T., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
10. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 death among 75,000 women. Lancet 339 (1992) 1-15
11. Gabriele P., Orecchia R., Ragona R., et al. A cooperative AIRO/Piemonte randomized clinical trial of carboplatin as an adjunct to radiotherapy in head and neck cancer. Radiat Oncol 32 (1994) S93
12. Bhowmik K.T., Safaya A., Sharma R., Suri K., Bhatia J.S., and Das Nl. Concomitant chemoradiotherapy in advanced head and neck cancers: Safdarjang hospital experience. Radiat Oncol 58 (2001) S16
13. Haselow R.E., Warshaw M.G., Oken M.M., et al. Radiation alone versus radiation with weekly low dose cisplatinum in unrescetable cancer of the head and neck. In: Fee Jr. W.E., Goepfert H., Johns M.E., et al. (Eds). Head and neck cancer vol. II (1990), BC Decker, Philadelphia 279-281
14. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: an individual patient data meta-analysis of 15 randomized trials. Lancet 368 (2006) 843-854
15. Available from: http://www.emea.europa.eu/humandocs/PDFs/EPAR/erbitux/Erbitux-H-558-II-05.pdf [last access on November 26, 2008].
16. Hitt R., Lopez-Pousa A., Martinez-Trufero J., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 (2005) 8636-8645
17. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
18. Vermorken J.B., Remenar E., van Herpen C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
19. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354 (2006) 567-578